Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20921390 | 1.00 | PTGS2 (0.77) | PTGS2PTGS1 | |
| SCHEMBL16893671 | 0.91 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL16893551 | 0.91 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL16893554 | 0.91 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL16893673 | 0.91 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL20646313 | 0.90 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL20921364 | 0.90 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL16925135 | 0.88 | PTGS2 (0.69) | PTGS2PTGS1 | |
| SCHEMBL16893545 | 0.87 | PTGS2 (1.00) | PTGS2PTGS1 | |
| SCHEMBL16893543 | 0.87 | PTGS2 (1.00) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3094333-B1 | NO-RELEASING NITROOXY-CHROMENE CONJUGATES | EUCLISES PHARMACEUTICALS INC (US) | 2020-10-14 | — | — | EP | disclosed |
| US-10414744-B2 | 4-sulfur pentafluoride phenol compound and preparation method therefor, and preparation method for sulfur pentafluoride substituted benzopyran compound | Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences (CN) | 2019-09-17 | — | — | US | disclosed |
| US-20190084957-A1 | 4-SULFUR PENTAFLUORIDE PHENOL COMPOUND AND PREPARATION METHOD THEREFOR, AND PREPARATION METHOD FOR SULFUR PENTAFLUORIDE SUBSTITUTED BENZOPYRAN COMPOUND | Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences (CN) | 2019-03-21 | — | — | US | disclosed |
| EP-3428154-A1 | 4-SULFUR PENTAFLUORIDE PHENOL COMPOUND AND PREPARATION METHOD THEREFOR, AND PREPARATION METHOD FOR SULFUR PENTAFLUORIDE SUBSTITUTED BENZOPYRAN COMPOUND | Guangzhou Institutes Of Biomedicine And Health Chinese Academy Of Sciences (CN) | 2019-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190084957-A1 | 4-SULFUR PENTAFLUORIDE PHENOL COMPOUND AND PREPARATION METHOD THEREFOR, AND PREPARATION METHOD FOR SULFUR PENTAFLUORIDE SUBSTITUTED BENZOPYRAN COMPOUND | SALL4, FGFR4, CYP4F11 | PTGS2 2383/4885PTGS1 2136/4885 |
| US-10414744-B2 | 4-sulfur pentafluoride phenol compound and preparation method therefor, and preparation method for sulfur pentafluoride substituted benzopyran compound | SALL4, FGFR4, CYP4F11 | PTGS2 2383/4885PTGS1 2136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.